CCL17 and neoplasm: When co-culturing CAR T cells with TB32043mb6s2 cells in vitro, a significant secretion of CXCL2, CXCL16 and CCL17 was observed, which are potentially tumour-promoting factors that could hinder therapeutic efficacy in vivo (Figure 3c).